Triple combo cystic fibrosis therapy Kaftrio scores EU label expansion

29th April 2021 Uncategorised 0

Extension means the ‘majority’ of people aged 12 years and older with CF in Europe can now access therapy

More: Triple combo cystic fibrosis therapy Kaftrio scores EU label expansion
Source: News